跳至主要内容
临床试验/NCT01507363
NCT01507363已完成4 期

Analgesic Effect of Perioperative Gabapentin in Total Knee Arthroplasty: A Randomized, Double-blind, Placebo-controlled, Dose-response Study

Hvidovre University Hospital3 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
300
试验地点
3
主要终点
Pain

研究概览

简要总结

Pain is a major problem after TKA. Gabapentin may reduce acute postoperative pain. The investigators therefore investigate the effect of Gabapentin as a perioperative analgesic.

详细描述

Pain is a major problem after TKA. Studies indicate that Gabapentin may reduce acute postoperative pain. However, the optimal dose is unknown and there is constant controversy on analgesic versus side-effects. The investigators therefore investigate the effect of Gabapentin as a perioperative analgesic in a dose-related manner and with a sample-size allowing evaluation of side-effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary, unilateral total knee arthroplasty (TKA)
  • Age 50-85 years
  • Ethnic Danes

排除标准

  • Treatment with gabapentins, systemic glucocorticoids, opioids, anxiolytic agents, antiepileptics or antidepressive agents (last 4 weeks)
  • History of depression or mania
  • History of alcohol or drug abuse
  • History of malignancy
  • History of epilepsia
  • BMI > 40
  • Disease affecting central or peripheral nerve function
  • History of dementia
  • History of renal insufficiency
  • Allergy to Gabapentin
  • Women with menstruation (last 2 years)

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo tablets for 7 days, starting on the day of surgery

干预措施: Placebo (Drug)

Gabapentin "high"

Active Comparator

Tables with Gabapentin (1300 mg/day) for 7 days, starting on the day of surgery

干预措施: Gabapentin (Drug)

Gabapentin "intermediate"

Active Comparator

Tables with Gabapentin for 7 days (900 mg/day), starting on the day of surgery

干预措施: Gabapentin (Drug)

结局指标

主要结局

Pain

时间窗: At 24 hour

Pain during walking at 24 hour after surgery, visuel analog scale (VAS, 0-100 mm)

次要结局

  • Amount of ondansetron and sleeping medicine(1 week)
  • Anxiety and depression(1 week)
  • Gabapentin level in blood-sample(1 Day)
  • Sedation(At 6 hours)
  • Pain(1 week)
  • Cumulated pain scores(1 week)
  • Amount of rescue analgesic(1 week)
  • Side effects(1 week)
  • Cumulated side effects scores(1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Troels Haxholdt Lunn

MD, principal and koordinating investigator

Hvidovre University Hospital

研究点 (3)

Loading locations...

相似试验